Stay updated on Tildrakizumab for Chronic Plaque Psoriasis Clinical Trial

Sign up to get notified when there's something new on the Tildrakizumab for Chronic Plaque Psoriasis Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Tildrakizumab for Chronic Plaque Psoriasis Clinical Trial page

  1. Check
    7 days ago
    No Change Detected
  2. Check
    14 days ago
    Change Detected
    Summary
    The page shows a site revision indicator (Revision: v3.4.2) and removal of prior notices about funding and operating status, with no change to the study details or core content. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.4%
    Check dated 2026-02-11T05:50:22.000Z thumbnail image
  3. Check
    21 days ago
    Change Detected
    Summary
    Added a site-wide notice about government funding and the NIH Clinical Center's status. Updated the page revision from v3.4.0 to v3.4.1.
    Difference
    0.4%
    Check dated 2026-02-04T05:53:22.000Z thumbnail image
  4. Check
    28 days ago
    Change Detected
    Summary
    Added a glossary toggle and new metadata lines: Last Update Submitted that Met QC Criteria, No FEAR Act Data, and Revision: v3.4.0. Removed the previous lines: Last Update Submitted that met QC Criteria, No FEAR Act data, and Revision: v3.3.4.
    Difference
    0.2%
    Check dated 2026-01-28T04:13:37.000Z thumbnail image
  5. Check
    42 days ago
    Change Detected
    Summary
    Footer shows Revision: v3.3.4, replacing the previous Revision: v3.3.3.
    Difference
    0.1%
    Check dated 2026-01-14T02:54:08.000Z thumbnail image
  6. Check
    63 days ago
    Change Detected
    Summary
    The page now displays Revision: v3.3.3. References to HHS Vulnerability Disclosure and Revision: v3.3.2 have been removed.
    Difference
    0.1%
    Check dated 2025-12-23T17:19:24.000Z thumbnail image
  7. Check
    92 days ago
    Change Detected
    Summary
    The Publications section had minor editorial updates: wording about publications and PubMed sources was refined and the revision tag changed from v3.2.0 to v3.3.2. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.2%
    Check dated 2025-11-24T17:52:18.000Z thumbnail image

Stay in the know with updates to Tildrakizumab for Chronic Plaque Psoriasis Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Tildrakizumab for Chronic Plaque Psoriasis Clinical Trial page.